Bristol Myers Squibb Reports Second Quarter 2020 Financial Results
The Pharma Data
AUGUST 6, 2020
NEW YORK–( BUSINESS WIRE )– Bristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2020, which reflect strong product sales, continued advancement of the pipeline and robust operating performance. chairman and chief executive officer, Bristol Myers Squibb. Oncology and Hematology. Regulatory.
Let's personalize your content